Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literature

By                    

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 117-122

Spandidos Publications

Access to resources Recommend Favorite

A case of long-term recurrence-free poorly differentiated neuroendocrine carcinoma of lymph nodes treated by surgical resection without any chemotherapy

By Hisamori Shigeo   Okabe Hiroshi   Yoshizawa Akihiko   Sakai Yoshiharu  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 493-496

Springer Publishing Company

Access to resources Recommend Favorite

Combined neuroendocrine carcinoma and adenocarcinoma in the stomach: A case report

By        

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 953-955

Spandidos Publications

Access to resources Recommend Favorite

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer

By Takahari Daisuke   Shimada Yasuhiro   Takeshita Shigeyuki   Nishitani Hitoshi   Takashima Atsuo   Okita Natsuko   Hirashima Yoshinori   Kato Ken   Hamaguchi Tetsuya   Yamada Yasuhide   Shirao Kuniaki  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 186-190

Springer Publishing Company

Access to resources Recommend Favorite

NEUROENDOCRINE TUMORS

By  

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 55-56

Informa Healthcare

Access to resources Recommend Favorite